Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 77Cutaneous Melanoma Detection and ManagementMedical Imaging Techniques and ApplicationsLung Cancer Diagnosis and Treatment

The DOI matches its Crossref record; 16 of the 27 references it cites were found in a registry or an index.

The rapid assessment of fatigue severity in cancer patients

Mendoza, Tito R., Wang, X. Shelley, Cleeland, Charles S., Morrissey, Marilyn, Johnson, Beth A., Wendt, Judy K., Huber, Stephen L.·1999·Cancer
DOI 10.1002/(sici)1097-0142(19990301)85:5
Open this paper in CoChat — free account

Abstract

BACKGROUND: High grade surface osteosarcoma is a rare subtype of osteosarcoma arising on the surface of bone, accounting for only 8.9% of surface osteosarcomas at the study institution. METHODS: This study reviews 46 cases of high grade surface osteosarcoma, comprised of 13 cases from the Mayo Clinic files and 33 from the authors' files. Histologic features were reviewed in all cases, and radiographs were reviewed in 29 cases. RESULTS: There was a definite male predominance, and 70% of the patients were in the second and third decades of life. Forty-four of the 46 patients had lesions involving the long bones, the most common site being the midportion of the femur. Radiographically, the majority of lesions showed dense to moderate mineralization with a fluffy, immature appearance. Radiating spicules of bone perpendicular to the long axis of the bone, characteristic of periosteal osteosarcoma, were sparse. Histologic findings were identical to those of conventional osteosarcoma. Overall, survival at 5 years was 46.1%. Statistical analysis revealed that marginal excision was associated with an increased risk of local recurrence and that the patients with Broders Grade 3 tumors had a better prognosis than those with Grade 4 tumors. A good response to chemotherapy was associated with better clinical outcome. CONCLUSIONS: High grade surface osteosarcoma is a rare subtype of surface osteoscarcoma that has a prognosis similar to that of conventional osteosarcoma, in contrast to the more common type of osteosarcoma arising on the surface of bone. Wide excision and effective systemic chemotherapy are associated with better clinical results.

Overview

Integrity signals

Registry

Crossref · 10.1002/(sici)1097-0142(19990301)85:5<1186::aid-cncr24>3.0.co;2-n

Cites

16 of 27 references verified0 citation errors · 11 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Cited by

See all 77

Metadata

Authors
Mendoza, T. R., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. K., & Huber, S. L.
Venue
Cancer
Publisher
Wiley
Published
1999-03-01
Volume
85
Issue
5
Pages
1186-1196
DOI
10.1002/(sici)1097-0142(19990301)85:5
OpenAlex
W7131823493
Cited by
1
References
26
Citations by year
2024: 1
FWCI
0.00
Type
journal article
Language
en
Open access
closed
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 6028 d)
Locations
Pure Amsterdam UMC (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
Keywords
high-risk melanoma, whole-body FDG PET, primary staging, follow-up, metastasis detection, melanoma recurrence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The rapid assessment of fatigue severity in cancer patients. https://app.cochat.ai/papers/10.1002/(sici)1097-0142(19990301)85:5
The paper
Mendoza, T. R., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. K., & Huber, S. L. (1999). The rapid assessment of fatigue severity in cancer patients. Cancer. https://doi.org/10.1002/(sici)1097-0142(19990301)85%3A5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.